<scp>SGLT2</scp> inhibitor therapy and lower incidence of iron deficiency anaemia in patients with type 2 diabetes: A retrospective cohort study from Germany
SGLT2i therapy was associated with a lower incidence of IDA in T2DM patients compared to DPP-4i therapy. These findings suggest a potential hematologic benefit of SGLT2 inhibitors, warranting further investigation in randomised controlled trials.
Authors
- Karel Kostev (ORCID: https://orcid.org/0000-0002-2124-7227)
- Theresia Sarabhai (ORCID: https://orcid.org/0009-0008-2385-5200)
Institutions
- Philipps University of Marburg (DE)
- Essen University Hospital (DE)
- University of Duisburg-Essen (DE)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1111/dom.70057
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- Deutsche Forschungsgemeinschaft